News Sentiment

EWTX sentiment intelligence

Edgewise Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 45.41 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+14.8% over one week, +30.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Positive Trial Results Propel Edgewise's (EWTX) Plans for Phase 3 Development

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 14.8% Price confirming higher
Trend fit Trend active 30.4% over four weeks
Fair value 124.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 31
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 10
PR Newswire 4
MT Newswires 4
Moomoo 3
simplywall.st 3
Stocktwits 3
TradingView 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 10
Deals and strategy 3
Analyst action 3
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47